Photobiomodulation with the Valeda light delivery system was authorized in November 2024, and we have been treating patients with it since summer 2025.
It seems too simple to be true that we could shine a light in someone’s eyes for a few minutes nine times every 4 months and that it would help either regenerate or slow the aging process in the retina. The premise is that shining a combination of three wavelengths of light (590 nm, 660 nm and 850 nm) into the eye helps activate the mitochondria in retinal cells.
The study to gain FDA authorization was relatively small, 148 eyes over 2